Modified DNA vaccine confers improved humoral immune response and effective virus protection against SARS-CoV-2 delta variant

Coronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has led to a global pandemic. New technologies have been utilized to develop several types of vaccines to prevent the spread of SARS-CoV-2 infection, including mRNA vaccines. Our group previo...

Descripción completa

Detalles Bibliográficos
Autores principales: Hayashi, Hiroki, Sun, Jiao, Yanagida, Yuka, Otera, Takako, Sasai, Miwa, Chang, Chin Yang, Tai, Jiayu A., Nishikawa, Tomoyuki, Yamashita, Kunihiko, Sakaguchi, Naoki, Yoshida, Shota, Baba, Satoshi, Shimamura, Munehisa, Okamoto, Sachiko, Amaishi, Yasunori, Chono, Hideto, Mineno, Junichi, Rakugi, Hiromi, Morishita, Ryuichi, Yamamoto, Masahiro, Nakagami, Hironori
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9719526/
https://www.ncbi.nlm.nih.gov/pubmed/36463322
http://dx.doi.org/10.1038/s41598-022-24519-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9719526/
https://www.ncbi.nlm.nih.gov/pubmed/36463322
http://dx.doi.org/10.1038/s41598-022-24519-5

Ejemplares similares